Original Article

Split Viewer

Korean J Hematol 2012; 47(2):

Published online June 26, 2012

https://doi.org/10.5045/kjh.2012.47.2.105

© The Korean Society of Hematology

Arsenic trioxide induces depolymerization of microtubules in an acute promyelocytic leukemia cell line

Jin Ho Baek1,#, Chang Hoon Moon2,#, Seung Joo Cha2, Hee Soon Lee2, Eui-Kyu Noh1,2, Hawk Kim1,2, Jong-Ho Won3, and Young Joo Min1,2*

1Division of Hematology and Oncology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.

2Biomedical Research Center, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.

3Division of Hematology-Oncology, Soonchunhyang University College of Medicine, Seoul, Korea.

Correspondence to : Correspondence to Young Joo Min, M.D., Ph.D. Biomedical Research Center, Ulsan University Hospital, University of Ulsan College of Medicine, 290-3, Jeonha-dong, Dong-gu, Ulsan 682-714, Korea. Tel: +82-52-250-8832, Fax: +82-52-250-8520, yjmin@uuh.ulsan.kr

Received: March 9, 2012; Revised: May 7, 2012; Accepted: May 16, 2012

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Arsenic trioxide (As2O3) is a well-known and effective treatment that can result in clinical remission for patients diagnosed with acute promyelocytic leukemia (APL). The biologic efficacy of As2O3 in APL and solid tumor cells has been explained through its actions on anti-proliferation, anti-angiogenesis, and apoptotic signaling pathways. We theorize that As2O3 activates a pathway that disrupts microtubule dynamics forming abnormal, nonfunctioning mitotic spindles, thus preventing cellular division. In this study, we investigated how As2O3 induces apoptosis by causing microtubule dysfunction.

Methods

Cultured NB4 cells were treated with As2O3, paclitaxel, and vincristine. Flow cytometric analysis was then performed. An MTT assay was used to determine drug-mediated cytotoxicity. For tubulin polymerization assay, each polymerized or soluble tubulin was measured. Microtubule assembly-disassembly was measured using a tubulin polymerization kit. Cellular microtubules were also observed with fluorescence microscopy.

Results

As2O3 treatment disrupted tubulin assembly resulting in dysfunctional microtubules that cause death in APL cells. As2O3 markedly enhanced the amount of depolymerized microtubules. The number of microtubule posttranslational modifications on an individual tubulin decreased with As2O3 concentration. Immunocytochemistry revealed changes in the cellular microtubule network and formation of polymerized microtubules in As2O3-treated cells.

Conclusion

The microtubules alterations found with As2O3 treatment suggest that As2O3 increases the depolymerized forms of tubulin in cells and that this is potentially due to arsenite's negative effects on spindle dynamics.

Keywords Acute promyelocytic leukemia, Arsenic trioxide, Tubulin, Apoptosis, Antimitotic agents

Article

Original Article

Korean J Hematol 2012; 47(2): 105-112

Published online June 26, 2012 https://doi.org/10.5045/kjh.2012.47.2.105

Copyright © The Korean Society of Hematology.

Arsenic trioxide induces depolymerization of microtubules in an acute promyelocytic leukemia cell line

Jin Ho Baek1,#, Chang Hoon Moon2,#, Seung Joo Cha2, Hee Soon Lee2, Eui-Kyu Noh1,2, Hawk Kim1,2, Jong-Ho Won3, and Young Joo Min1,2*

1Division of Hematology and Oncology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.

2Biomedical Research Center, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.

3Division of Hematology-Oncology, Soonchunhyang University College of Medicine, Seoul, Korea.

Correspondence to:Correspondence to Young Joo Min, M.D., Ph.D. Biomedical Research Center, Ulsan University Hospital, University of Ulsan College of Medicine, 290-3, Jeonha-dong, Dong-gu, Ulsan 682-714, Korea. Tel: +82-52-250-8832, Fax: +82-52-250-8520, yjmin@uuh.ulsan.kr

Received: March 9, 2012; Revised: May 7, 2012; Accepted: May 16, 2012

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Arsenic trioxide (As2O3) is a well-known and effective treatment that can result in clinical remission for patients diagnosed with acute promyelocytic leukemia (APL). The biologic efficacy of As2O3 in APL and solid tumor cells has been explained through its actions on anti-proliferation, anti-angiogenesis, and apoptotic signaling pathways. We theorize that As2O3 activates a pathway that disrupts microtubule dynamics forming abnormal, nonfunctioning mitotic spindles, thus preventing cellular division. In this study, we investigated how As2O3 induces apoptosis by causing microtubule dysfunction.

Methods

Cultured NB4 cells were treated with As2O3, paclitaxel, and vincristine. Flow cytometric analysis was then performed. An MTT assay was used to determine drug-mediated cytotoxicity. For tubulin polymerization assay, each polymerized or soluble tubulin was measured. Microtubule assembly-disassembly was measured using a tubulin polymerization kit. Cellular microtubules were also observed with fluorescence microscopy.

Results

As2O3 treatment disrupted tubulin assembly resulting in dysfunctional microtubules that cause death in APL cells. As2O3 markedly enhanced the amount of depolymerized microtubules. The number of microtubule posttranslational modifications on an individual tubulin decreased with As2O3 concentration. Immunocytochemistry revealed changes in the cellular microtubule network and formation of polymerized microtubules in As2O3-treated cells.

Conclusion

The microtubules alterations found with As2O3 treatment suggest that As2O3 increases the depolymerized forms of tubulin in cells and that this is potentially due to arsenite's negative effects on spindle dynamics.

Keywords: Acute promyelocytic leukemia, Arsenic trioxide, Tubulin, Apoptosis, Antimitotic agents

Fig 1.

Figure 1.

Induction of cytotoxicity and cell cycle arrest by As2O3. (A) To show the inhibitory effects of As2O3 on the cell proliferation, exponentially growing cells were treated with the indicated concentrations of As2O3 for 24 hour and 48 hours, and cell proliferation was assessed by using the MTS reagent (see Materials and Methods). The cytotoxic effect of As2O3 was increased in a concentration- and/or time-dependent manner. These data represent the mean±SD of independent experiments. (B) To observe the apoptotic effects of As2O3, NB4 cells were treated with either a vehicle (control) or each concentration of As2O3 and paclitaxel for 24 hours. PI-stained cells were analyzed by flow cytometry as described in the Materials and Methods section, and the percentage of cells in each phase of the cell cycle was analyzed using flow cytometry (Table 1). Flow cytometry analysis revealed a significant increased apoptotic effect that resulted in a concentration-dependent accumulation of NB4 cells in the G2/M phase on the As2O3-treated cells.

Blood Research 2012; 47: 105-112https://doi.org/10.5045/kjh.2012.47.2.105

Fig 2.

Figure 2.

Alterations in tubulin polymerization induced by As2O3. (A) To demonstrate that the fraction of depolymerized tubulin is increased after treatment with As2O3, NB4 cells were treated with drugs or without drugs as a control for 6 hours at the indicated concentrations. Cell lysates were separated into polymerized (P) or soluble (S) fractions. Aliquots of equal volume were separated on an SDS-PAGE gel, and evaluated by western blotting with an anti α-tubulin antibody. Compared to the baseline proportion of α-tubulin in the soluble fraction, the depolymerized proportion observed after treatment of As2O3 was approximately 52-72% and the tubulin shift to the "S" fraction was noted. (B) To show the effects of a combination of drugs, NB4 cells were treated with 5 µM As2O3, 10 µM As2O3 and 40 nM paclitaxel at alone or in combination, and treated for 6 hours. Cell lysates were separated into "P" or "S" fractions as described above. Aliquots of equal volume were loaded onto SDS-PAGE gels, and the blots probed with antibody against α-tubulin. The results indicate that As2O3 and paclitaxel did not synergistically influence microtubule assembly. The intensity of each band was quantified by densitometry and the percentage of soluble tubulin (%S) was calculated by multiplying the fraction of tubulin in the soluble fraction [S/(S+P)] by 100 for each "S-P" pair.

Blood Research 2012; 47: 105-112https://doi.org/10.5045/kjh.2012.47.2.105

Fig 3.

Figure 3.

Effects of As2O3 on microtubule stabilization. NB4 cells were treated with drugs or no drugs as a control, for 6 hours and 24 hours at the indicated concentration. Lysates were separated into polymerized (P) or soluble (S) fractions. The blots probed with anti-acetylated α-tubulin. The amount of acetylated α-tubulin in the P fraction of paclitaxel treatment was increased, compared with that of the control, but the proportion in P fraction of As2O3 treatment was decreased in a concentration-dependent manner. This result indicated that As2O3 interfered with important modifications necessary for the stability of microtubules. The intensity of each band was quantified by densitometry and the blots were stripped and reprobed with GAPDH-specific antibody as a loading control.

Blood Research 2012; 47: 105-112https://doi.org/10.5045/kjh.2012.47.2.105

Fig 4.

Figure 4.

Effects of As2O3 on microtubule polymerization in vitro. Purified tubulin from bovine brain tissue (Cytoskeleton) was incubated at 37℃ in reaction mixtures containing 1 mM GTP, 10 nM paclitaxel (Taxol), 10 nM vincristine, 5 µM As2O3 and the mock-treated solution as a control. Tubulin polymerization was determined by measuring absorbance at 340 nm. This revealed that As2O3 directly influences tubulin and induces tubulin depolymerization.

Blood Research 2012; 47: 105-112https://doi.org/10.5045/kjh.2012.47.2.105

Fig 5.

Figure 5.

Effects of As2O3 on the organization of cellular microtubule network. NB4 cells were treated with 5 µM As2O3, 40 nM paclitaxel, and 20 nM vincristine. Mock-treated cells were used as a control. After a 6-hour incubation, cells were harvested and fixed with formaldehyde. Cells were incubated with monoclonal anti-α-tubulin antibody at room temperature for 30 minutes. After incubation with FITC-conjugated secondary antibody, the cellular microtubules were imaged using an Olympus IX-81 fluorescence microscope. The normal organization of microtubule network was seen in control cells, increased density of polymerized microtubules were found in paclitaxel-treated cells, and a degraded microtubule network in cytoplasm was observed in As2O3-and vicristine-treated cells.

Blood Research 2012; 47: 105-112https://doi.org/10.5045/kjh.2012.47.2.105

Table 1 . Cell cycle distribution of cells treated with arsenic trioxide and paclitaxel for 24 hours..

a)Percentage of cells in each phase of the cell cycle following 24 hours of drug treatment..


Blood Res
Volume 59 2024

Stats or Metrics

Share this article on

  • line

Related articles in BR

Blood Research

pISSN 2287-979X
eISSN 2288-0011
qr-code Download